Malik; Asrar B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Malik; Asrar B..The latest application filed is for "peptides for inhibiting angiogenesis".

Company Profile

0.9.10

Malik; Asrar B. - Hinsdale IL
Malik; Asrar B. - Chicago IL US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptides for treating cancer Grant 10,064,911 - Komarova , et al. September 4, 2	2018-09-04
Peptides for Inhibiting Angiogenesis App 20170258868 - Komarova; Yulia A. ; et al.	2017-09-14
Peptides for inhibiting angiogenesis Grant 9,675,660 - Komarova , et al. June 13, 2	2017-06-13
Peptides For Inhibiting Angiogenesis App 20160256518 - Komarova; Yulia A. ; et al.	2016-09-08
Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion Grant 9,248,198 - Komarova , et al. February 2, 2	2016-02-02
Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion Grant 8,912,139 - Komarova , et al. December 16, 2	2014-12-16
Peptide Compositions And Methods For Treating Lung Injury, Asthma, Anaphylaxis, Angioedema, Systemic Vascular Permeability Syndromes, And Nasal Congestion App 20140213505 - Komarova; Yulia A. ; et al.	2014-07-31
Peptide Compositions And Methods For Treating Lung Injury, Asthma, Anaphylaxis, Angioedema, Systemic Vascular Permeability Syndromes, And Nasal Congestion App 20140155314 - Komarova; Yulia A. ; et al.	2014-06-05
CBLB for treating endotoxin-mediated disorders Grant 8,168,176 - Bachmaier , et al. May 1, 2	2012-05-01
Selected endothelial progenitor cells and methods for use Grant 8,137,968 - Wary , et al. March 20, 2	2012-03-20
Silencing of TGF.beta. type II receptor expression by siRNA Grant 8,067,389 - Kumar , et al. November 29, 2	2011-11-29
Compositions And Methods For Treating Pulmonary Hypertension App 20110171193 - Zhao; You-Yang ; et al.	2011-07-14
CBLB for Treating Endotoxin-Mediated Disorders App 20100061970 - Bachmaier; Kurt ; et al.	2010-03-11
Silencing Of Tgf Beta Type Ii Receptor Expression By Sirna App 20090318537 - KUMAR; NALIN M. ; et al.	2009-12-24
Peptide carrier for drug delivery Grant 7,429,563 - Tiruppathi , et al. September 30, 2	2008-09-30
Selected endothelial progenitor cells and methods for use App 20080206200 - Wary; Kishore K. ; et al.	2008-08-28
Peptide carrier for drug delivery App 20070077239 - Tiruppathi; Chinnaswamy ; et al.	2007-04-05
Silencing of tgf-beta receptor type II expression by sirna App 20060229266 - Kumar; Nalin M. ; et al.	2006-10-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.